Loading…

A Neuropsychiatric Perspective of Phenylketonuria I: Overview of Phenylketonuria and Its Neuropsychiatric Sequelae

Phenylketonuria (PKU) is an autosomal recessive metabolic genetic disorder that is associated with neuropsychiatric sequelae of varying severity. The natural history, epidemiology, and a history of the medical understanding and approaches to treatment of PKU are presented. Neurocognitive and neurops...

Full description

Saved in:
Bibliographic Details
Published in:Psychosomatics (Washington, D.C.) D.C.), 2012-11, Vol.53 (6), p.517-523
Main Authors: Bone, Ashley, M.D, Kuehl, Angela K., Pharm.D., M.S, Angelino, Andrew F., M.D., D.F.A.P.A
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c485t-f6e3c731fbcf48edd9897957450476ef4a1c1f8a8a72afce6005e43bc24cfa2e3
cites cdi_FETCH-LOGICAL-c485t-f6e3c731fbcf48edd9897957450476ef4a1c1f8a8a72afce6005e43bc24cfa2e3
container_end_page 523
container_issue 6
container_start_page 517
container_title Psychosomatics (Washington, D.C.)
container_volume 53
creator Bone, Ashley, M.D
Kuehl, Angela K., Pharm.D., M.S
Angelino, Andrew F., M.D., D.F.A.P.A
description Phenylketonuria (PKU) is an autosomal recessive metabolic genetic disorder that is associated with neuropsychiatric sequelae of varying severity. The natural history, epidemiology, and a history of the medical understanding and approaches to treatment of PKU are presented. Neurocognitive and neuropsychiatric sequelae of patients with untreated, early-treated, and continuously-treated PKU are described, and possible mechanisms for the symptoms are proposed. The authors propose an integrated approach to management of patients with PKU.
doi_str_mv 10.1016/j.psym.2012.04.010
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1178726169</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0033318212000795</els_id><sourcerecordid>1178726169</sourcerecordid><originalsourceid>FETCH-LOGICAL-c485t-f6e3c731fbcf48edd9897957450476ef4a1c1f8a8a72afce6005e43bc24cfa2e3</originalsourceid><addsrcrecordid>eNp9kkFr2zAYhsXYWLNuf2CH4ctgF7v6JFmySxmUsraB0ha6nYUif6JKHTuV7Iz8-8kkW6EdPemg530lPfoI-Qy0AAryaFms43ZVMAqsoKKgQN-QGZSizBWj8i2ZUcp5zqFiB-RDjEtKaQmlfE8OGIdS1TXMSDjNrnEMfWqy994MwdvsFkNcox38BrPeZbf32G3bBxz6bgzeZPPj7GaDYePx9_-2Tddk8yG-rL3DxxFbgx_JO2faiJ_26yH5df7j59llfnVzMT87vcqtqMohdxK5VRzcwjpRYdPUVa3qUomSCiXRCQMWXGUqo5hxFmV6HQq-sExYZxjyQ_Jt17sOfTo5Dnrlo8W2NR32Y9QAqlJMgqwTynaoDX2MAZ1eB78yYauB6sm1XurJtZ5cayp0cp1CX_b942KFzb_IX7kJ-LoHTLSmdcF01scnTioKFReJO9lxmGwkrUFH67Gz2PiQvkE3vX_9Ht-fxW3rO59OfMAtxmU_hi551qBjyui7aSqmoQCWBiIZ5X8AOWO0fw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1178726169</pqid></control><display><type>article</type><title>A Neuropsychiatric Perspective of Phenylketonuria I: Overview of Phenylketonuria and Its Neuropsychiatric Sequelae</title><source>ScienceDirect Freedom Collection</source><creator>Bone, Ashley, M.D ; Kuehl, Angela K., Pharm.D., M.S ; Angelino, Andrew F., M.D., D.F.A.P.A</creator><creatorcontrib>Bone, Ashley, M.D ; Kuehl, Angela K., Pharm.D., M.S ; Angelino, Andrew F., M.D., D.F.A.P.A</creatorcontrib><description>Phenylketonuria (PKU) is an autosomal recessive metabolic genetic disorder that is associated with neuropsychiatric sequelae of varying severity. The natural history, epidemiology, and a history of the medical understanding and approaches to treatment of PKU are presented. Neurocognitive and neuropsychiatric sequelae of patients with untreated, early-treated, and continuously-treated PKU are described, and possible mechanisms for the symptoms are proposed. The authors propose an integrated approach to management of patients with PKU.</description><identifier>ISSN: 0033-3182</identifier><identifier>EISSN: 1545-7206</identifier><identifier>DOI: 10.1016/j.psym.2012.04.010</identifier><identifier>PMID: 23157991</identifier><language>eng</language><publisher>Arlington, VA: Elsevier Inc</publisher><subject>Age Factors ; Aminoacid disorders ; Biological and medical sciences ; Brain - metabolism ; Brain - physiopathology ; Child ; Child Behavior Disorders - etiology ; Cognition Disorders - blood ; Cognition Disorders - etiology ; Cognition Disorders - psychology ; Developmental Disabilities - blood ; Developmental Disabilities - etiology ; Diet, Protein-Restricted ; Errors of metabolism ; Humans ; Internal Medicine ; Medical sciences ; Metabolic diseases ; Neuropsychiatry ; Patient Compliance ; Phenylalanine - blood ; Phenylketonurias - blood ; Phenylketonurias - complications ; Phenylketonurias - therapy ; Psychiatry ; Referral and Consultation</subject><ispartof>Psychosomatics (Washington, D.C.), 2012-11, Vol.53 (6), p.517-523</ispartof><rights>The Academy of Psychosomatic Medicine</rights><rights>2012 The Academy of Psychosomatic Medicine</rights><rights>2014 INIST-CNRS</rights><rights>Copyright © 2012 The Academy of Psychosomatic Medicine. Published by Elsevier Inc. All rights reserved.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c485t-f6e3c731fbcf48edd9897957450476ef4a1c1f8a8a72afce6005e43bc24cfa2e3</citedby><cites>FETCH-LOGICAL-c485t-f6e3c731fbcf48edd9897957450476ef4a1c1f8a8a72afce6005e43bc24cfa2e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=26701834$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23157991$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bone, Ashley, M.D</creatorcontrib><creatorcontrib>Kuehl, Angela K., Pharm.D., M.S</creatorcontrib><creatorcontrib>Angelino, Andrew F., M.D., D.F.A.P.A</creatorcontrib><title>A Neuropsychiatric Perspective of Phenylketonuria I: Overview of Phenylketonuria and Its Neuropsychiatric Sequelae</title><title>Psychosomatics (Washington, D.C.)</title><addtitle>Psychosomatics</addtitle><description>Phenylketonuria (PKU) is an autosomal recessive metabolic genetic disorder that is associated with neuropsychiatric sequelae of varying severity. The natural history, epidemiology, and a history of the medical understanding and approaches to treatment of PKU are presented. Neurocognitive and neuropsychiatric sequelae of patients with untreated, early-treated, and continuously-treated PKU are described, and possible mechanisms for the symptoms are proposed. The authors propose an integrated approach to management of patients with PKU.</description><subject>Age Factors</subject><subject>Aminoacid disorders</subject><subject>Biological and medical sciences</subject><subject>Brain - metabolism</subject><subject>Brain - physiopathology</subject><subject>Child</subject><subject>Child Behavior Disorders - etiology</subject><subject>Cognition Disorders - blood</subject><subject>Cognition Disorders - etiology</subject><subject>Cognition Disorders - psychology</subject><subject>Developmental Disabilities - blood</subject><subject>Developmental Disabilities - etiology</subject><subject>Diet, Protein-Restricted</subject><subject>Errors of metabolism</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Medical sciences</subject><subject>Metabolic diseases</subject><subject>Neuropsychiatry</subject><subject>Patient Compliance</subject><subject>Phenylalanine - blood</subject><subject>Phenylketonurias - blood</subject><subject>Phenylketonurias - complications</subject><subject>Phenylketonurias - therapy</subject><subject>Psychiatry</subject><subject>Referral and Consultation</subject><issn>0033-3182</issn><issn>1545-7206</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp9kkFr2zAYhsXYWLNuf2CH4ctgF7v6JFmySxmUsraB0ha6nYUif6JKHTuV7Iz8-8kkW6EdPemg530lPfoI-Qy0AAryaFms43ZVMAqsoKKgQN-QGZSizBWj8i2ZUcp5zqFiB-RDjEtKaQmlfE8OGIdS1TXMSDjNrnEMfWqy994MwdvsFkNcox38BrPeZbf32G3bBxz6bgzeZPPj7GaDYePx9_-2Tddk8yG-rL3DxxFbgx_JO2faiJ_26yH5df7j59llfnVzMT87vcqtqMohdxK5VRzcwjpRYdPUVa3qUomSCiXRCQMWXGUqo5hxFmV6HQq-sExYZxjyQ_Jt17sOfTo5Dnrlo8W2NR32Y9QAqlJMgqwTynaoDX2MAZ1eB78yYauB6sm1XurJtZ5cayp0cp1CX_b942KFzb_IX7kJ-LoHTLSmdcF01scnTioKFReJO9lxmGwkrUFH67Gz2PiQvkE3vX_9Ht-fxW3rO59OfMAtxmU_hi551qBjyui7aSqmoQCWBiIZ5X8AOWO0fw</recordid><startdate>20121101</startdate><enddate>20121101</enddate><creator>Bone, Ashley, M.D</creator><creator>Kuehl, Angela K., Pharm.D., M.S</creator><creator>Angelino, Andrew F., M.D., D.F.A.P.A</creator><general>Elsevier Inc</general><general>American Psychiatric Publishing</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20121101</creationdate><title>A Neuropsychiatric Perspective of Phenylketonuria I: Overview of Phenylketonuria and Its Neuropsychiatric Sequelae</title><author>Bone, Ashley, M.D ; Kuehl, Angela K., Pharm.D., M.S ; Angelino, Andrew F., M.D., D.F.A.P.A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c485t-f6e3c731fbcf48edd9897957450476ef4a1c1f8a8a72afce6005e43bc24cfa2e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Age Factors</topic><topic>Aminoacid disorders</topic><topic>Biological and medical sciences</topic><topic>Brain - metabolism</topic><topic>Brain - physiopathology</topic><topic>Child</topic><topic>Child Behavior Disorders - etiology</topic><topic>Cognition Disorders - blood</topic><topic>Cognition Disorders - etiology</topic><topic>Cognition Disorders - psychology</topic><topic>Developmental Disabilities - blood</topic><topic>Developmental Disabilities - etiology</topic><topic>Diet, Protein-Restricted</topic><topic>Errors of metabolism</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Medical sciences</topic><topic>Metabolic diseases</topic><topic>Neuropsychiatry</topic><topic>Patient Compliance</topic><topic>Phenylalanine - blood</topic><topic>Phenylketonurias - blood</topic><topic>Phenylketonurias - complications</topic><topic>Phenylketonurias - therapy</topic><topic>Psychiatry</topic><topic>Referral and Consultation</topic><toplevel>online_resources</toplevel><creatorcontrib>Bone, Ashley, M.D</creatorcontrib><creatorcontrib>Kuehl, Angela K., Pharm.D., M.S</creatorcontrib><creatorcontrib>Angelino, Andrew F., M.D., D.F.A.P.A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Psychosomatics (Washington, D.C.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bone, Ashley, M.D</au><au>Kuehl, Angela K., Pharm.D., M.S</au><au>Angelino, Andrew F., M.D., D.F.A.P.A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Neuropsychiatric Perspective of Phenylketonuria I: Overview of Phenylketonuria and Its Neuropsychiatric Sequelae</atitle><jtitle>Psychosomatics (Washington, D.C.)</jtitle><addtitle>Psychosomatics</addtitle><date>2012-11-01</date><risdate>2012</risdate><volume>53</volume><issue>6</issue><spage>517</spage><epage>523</epage><pages>517-523</pages><issn>0033-3182</issn><eissn>1545-7206</eissn><abstract>Phenylketonuria (PKU) is an autosomal recessive metabolic genetic disorder that is associated with neuropsychiatric sequelae of varying severity. The natural history, epidemiology, and a history of the medical understanding and approaches to treatment of PKU are presented. Neurocognitive and neuropsychiatric sequelae of patients with untreated, early-treated, and continuously-treated PKU are described, and possible mechanisms for the symptoms are proposed. The authors propose an integrated approach to management of patients with PKU.</abstract><cop>Arlington, VA</cop><pub>Elsevier Inc</pub><pmid>23157991</pmid><doi>10.1016/j.psym.2012.04.010</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0033-3182
ispartof Psychosomatics (Washington, D.C.), 2012-11, Vol.53 (6), p.517-523
issn 0033-3182
1545-7206
language eng
recordid cdi_proquest_miscellaneous_1178726169
source ScienceDirect Freedom Collection
subjects Age Factors
Aminoacid disorders
Biological and medical sciences
Brain - metabolism
Brain - physiopathology
Child
Child Behavior Disorders - etiology
Cognition Disorders - blood
Cognition Disorders - etiology
Cognition Disorders - psychology
Developmental Disabilities - blood
Developmental Disabilities - etiology
Diet, Protein-Restricted
Errors of metabolism
Humans
Internal Medicine
Medical sciences
Metabolic diseases
Neuropsychiatry
Patient Compliance
Phenylalanine - blood
Phenylketonurias - blood
Phenylketonurias - complications
Phenylketonurias - therapy
Psychiatry
Referral and Consultation
title A Neuropsychiatric Perspective of Phenylketonuria I: Overview of Phenylketonuria and Its Neuropsychiatric Sequelae
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T18%3A17%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Neuropsychiatric%20Perspective%20of%20Phenylketonuria%20I:%20Overview%20of%20Phenylketonuria%20and%20Its%20Neuropsychiatric%20Sequelae&rft.jtitle=Psychosomatics%20(Washington,%20D.C.)&rft.au=Bone,%20Ashley,%20M.D&rft.date=2012-11-01&rft.volume=53&rft.issue=6&rft.spage=517&rft.epage=523&rft.pages=517-523&rft.issn=0033-3182&rft.eissn=1545-7206&rft_id=info:doi/10.1016/j.psym.2012.04.010&rft_dat=%3Cproquest_cross%3E1178726169%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c485t-f6e3c731fbcf48edd9897957450476ef4a1c1f8a8a72afce6005e43bc24cfa2e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1178726169&rft_id=info:pmid/23157991&rfr_iscdi=true